These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4980851)

  • 21. Resistance of Melanesian elliptocytes (ovalocytes) to invasion by Plasmodium knowlesi and Plasmodium falciparum malaria parasites in vitro.
    Hadley T; Saul A; Lamont G; Hudson DE; Miller LH; Kidson C
    J Clin Invest; 1983 Mar; 71(3):780-2. PubMed ID: 6338046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross immunity in monkey malaria.
    Voller A; Garnham PC; Targett GA
    J Trop Med Hyg; 1966 Jun; 69(6):121-3. PubMed ID: 4957369
    [No Abstract]   [Full Text] [Related]  

  • 23. Inactivity of rodent malaria anti-sporozoite antibodies against exoerythrocytic forms.
    Vanderberg JP
    Am J Trop Med Hyg; 1973 Sep; 22(5):573-7. PubMed ID: 4580967
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro studies on erythrocytic stages of plasmodia; medium improvement and results with seven species of malarial parasites.
    Geiman QM; Siddigui WA; Schnell JV
    Mil Med; 1966 Sep; 131(9):Suppl:1015-25. PubMed ID: 4957805
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancement of a simian malarial infection (Plasmodium cynomolgi) in mosquitoes fed on rhesus (Macaca mulatta) previously infected with an unrelated malaria (Plasmodium knowlesi).
    de Arruda-Mayr M; Cochrane AH; Nussenzweig RS
    Am J Trop Med Hyg; 1979 Jul; 28(4):627-33. PubMed ID: 111568
    [No Abstract]   [Full Text] [Related]  

  • 26. Cultivation techniques for the erythrocytic stages of malaria parasites.
    Bertagna P; Cohen S; Geiman QM; Haworth J; Koenigk E; Richards WH; Trigg PI
    Bull World Health Organ; 1972; 47(3):357-73. PubMed ID: 4631043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of Plasmodium vivax-induced antigens on the surface of infected human erythrocytes.
    Mendis KN; Ihalamulla RI; David PH
    Am J Trop Med Hyg; 1988 Jan; 38(1):42-6. PubMed ID: 3277464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enzyme-linked immunosorbent assay (ELISA) for malaria. I. The use of in vitro-cultured Plasmodium falciparum as antigen.
    Spencer HC; Collins WE; Chin W; Skinner JC
    Am J Trop Med Hyg; 1979 Nov; 28(6):927-32. PubMed ID: 116555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium gallinaceum as antigen in immunofluorescence antibody studies.
    Kielmann A; Weiss N
    Acta Trop; 1968; 25(2):185-7. PubMed ID: 4386698
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages.
    Ockenhouse CF; Shear HL
    J Immunol; 1984 Jan; 132(1):424-31. PubMed ID: 6690606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short report: Rosette formation in Plasmodium ovale infection.
    Angus BJ; Thanikkul K; Silamut K; White NJ; Udomsangpetch R
    Am J Trop Med Hyg; 1996 Nov; 55(5):560-1. PubMed ID: 8940990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria.
    Langreth SG; Reese RT
    J Exp Med; 1979 Nov; 150(5):1241-54. PubMed ID: 91658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to plasmodial infections; consideration of factors relevant to malaria in man.
    McGregor IA
    Int Rev Trop Med; 1971; 4():1-52. PubMed ID: 4944095
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on immunity and serological reactions in monkeys after infection with Plasmodium cynomolgi bastianelli].
    Schindler R; Schröder G; Stieger R
    Z Tropenmed Parasitol; 1970 Sep; 21(3):239-45. PubMed ID: 4990718
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the cultivation of erythrocytic stage Plasmodium in vitro.
    Chen ZR; Gao MX; Li YH; Han SM; Zhang NL
    Chin Med J (Engl); 1980 Jan; 93(1):31-5. PubMed ID: 6768499
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro cultivation of the sporogonic stages of Plasmodium: a review.
    Vanderberg JP; Weiss MM; Mack SR
    Bull World Health Organ; 1977; 55(2-3):377-92. PubMed ID: 22406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malaria prevention. Chemotherapy and immune prophylaxis. 3. Immune response of infected organism. Perspectives of Malaria prevention].
    Wagner WH
    Arzneimittelforschung; 1986 Mar; 36(3):409-15. PubMed ID: 2423092
    [No Abstract]   [Full Text] [Related]  

  • 38. Structural aspects of Plasmodium relevant to vaccination against malaria.
    Bannister LH
    Trans R Soc Trop Med Hyg; 1977; 71(4):275-6. PubMed ID: 595077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antigens from erythrocytic stages of Plasmodium falciparum reacting with human immune sera.
    Perrin LH; Dayal R; Rieder H
    Trans R Soc Trop Med Hyg; 1981; 75(1):163-5. PubMed ID: 7022789
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of the in vitro growth of Plasmodium falciparum. I. The effects of immune serum and purified immunoglobulin from owl monkeys.
    Reese RT; Motyl MR
    J Immunol; 1979 Oct; 123(4):1894-9. PubMed ID: 113460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.